Stockscreener 앱 받기
0.3961
3.34%
0.0128
시간 외 거래:
.41
0.0139
+3.51%
전일 마감가:
$0.3833
열려 있는:
$0.38
하루 거래량:
2.91M
Relative Volume:
1.56
시가총액:
$47.21M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+58.00%
1개월 성능:
+55.58%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.36
$0.42
1주일 범위
$0.2418
$0.44
52주 변동 폭
$0.193
$6.43
Pomdoctor Ltd Adr Stock (POM) Company Profile
Compare POM vs HITI, PETS, RDGT, SCNX
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
POM
Pomdoctor Ltd Adr
|
0.3961 | 47.21M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.46 | 216.09M | 424.38M | -36.94M | 9.53M | -0.4206 |
|
PETS
Petmed Express Inc
|
2.46 | 52.65M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
RDGT
Ridgetech Inc
|
2.2086 | 40.39M | 119.97M | -1.45M | 632.50K | -0.9847 |
|
SCNX
Scienture Holdings Inc
|
0.4674 | 18.99M | 653.40K | -20.19M | -11.11M | -1.8091 |
Pomdoctor Ltd Adr 주식(POM)의 최신 뉴스
Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE) - GlobeNewswire Inc.
POM INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - ChartMill
POM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - Sahm
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM - ChartMill
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - ChartMill
Shareholders who lost money in American Depositary Receipts - GlobeNewswire
ROSEN, A LONGSTANDING FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming DeadlinesPOM - ChartMill
UPCOMING DEADLINE: Pomdoctor Limited (POM) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline - ChartMill
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - ChartMill
POM Investors with Large Losses Should Contact Robbins LLP for Information About the POMDoctor Ltd. Securities Class Action Lawsuit - Barchart.com
Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately - Barchart.com
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM) - ChartMill
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - Sahm
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - ChartMill
ROSEN, LEADING INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - ChartMill
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Sahm
POM Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against POMDoctor Ltd. - Barchart.com
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit - ChartMill
POM SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Sahm
Rosen Law Firm Urges PomDoctor Ltd. (NASDAQ: POM) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
Pomdoctor Deepens Medical Insurance Integration to Expand Online Chronic-Care Reach Across Major Chinese Cities - TipRanks
Pomdoctor Receives Nasdaq Deficiency Notice Over Minimum Bid Price - TipRanks
Pomdoctor expands online hospital business through pharma partnerships By Investing.com - Investing.com India
Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expansion in China - TipRanks
United States shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com
Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative - Sahm
Pomdoctor Limited Reports Strong Revenue Growth Amidst Challenging Conditions - TipRanks
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Benzinga
Citi (NYSE: C) extends Token Services in Dublin with Euro transfers, 24/7 liquidity - Stock Titan
Citi (NYSE: C) lowers base lending rate to 7.00%, effective Oct 30 at Citibank, N.A. - Stock Titan
Diluted shares outstanding of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED’s ADR Program - The AI Journal
Pomdoctor Ltd Adr (POM) 재무 분석
Pomdoctor Ltd Adr (POM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.23%
8.44%
자본화:
|
볼륨(24시간):